학술논문
O2 Serious infection, including severe COVID19, seems not to be a major clinical problem in patients with systemic lupus erythematosus treated with Belimumab, according the data from a large multicenter cohort
Document Type
article
Author
Íñigo Rúa-Figueroa; José A Gómez-Puerta; Javier Narváez; Eva Tomero; Clara Moriano; Elvira Díez Álvarez; Consuelo Ramos Giráldez; Maria Angeles Blazquez Cañamero; Maria Galindo Izquierdo; Jaime Calvo Alen; Jose Maria Pego Reigosa; Irene Altabás González; Beatriz Frade-Sosa; Margarida Vasques Rocha; Andrea Hernández-Martín; Paola Vidal-Montal; Eleonora Penzo; Marta de la Rubia Navarro; José Andrés Román Ivorra; Raul Menor Almagro; Tarek Salman Montes; Norman Jiménez Otero; Judit Font Urgelles; Ivette Casafont Sole; María Jesús García Villanueva; Carlos Marras Fernández; María Piqueras García; Julia Martínez Barrio; Marina Sánchez Lucas; Josefina Cortés Hernández; Myriam Gandía Martínez; Carmen Trapero Pérez; Alejandro Muñoz Jiménez
Source
Lupus Science and Medicine, Vol 11, Iss Suppl 1 (2024)
Subject
Language
English
ISSN
2053-8790